Ignite Creation Date:
2024-07-17 @ 12:04 PM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06470464
Status:
COMPLETED
Last Update Posted:
2024-06-24
First Post:
2024-06-17
Brief Title:
Thalidomide Combined With Chemotherapy in the Treatment of Relapsed or Refractory Yolk Sac Tumor
Sponsor:
Shandong First Medical University
Organization:
Shandong First Medical University
Organization Data
Organization:
Shandong First Medical University
Class:
OTHER
Study ID:
HERO2022
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Shandong First Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None